查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447964

北美毒理学实验室市场-北美行业分析,规模,占有率,成长,趋势,预测(2023-2030)-依药物类别,产品类型,样本,国家,公司

North America Toxicology Laboratories Market - North America Toxicology Laboratories Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Drug Class, By Product Type, By Sample, By Geographic Coverage and By Company)
出版日期: | 出版商: Fairfield Market Research | 英文 100 Pages | 商品交期: 2-5个工作天内

价格
简介目录

北美毒理学实验室市场规模预计将从 2023 年的 2.552 亿美元激增至 2030 年底的 5.112 亿美元，预测期内复合年增长率为 10.4%。

推动市场扩张的主要趋势包括快速筛选技术的重要性日益增加。气相层析质谱 (GC-MS) 等技术的进步增加了毒理学实验室对高效筛选方法的需求，从而增加了周转时间和灵敏度。

本报告中确定的另一个重要趋势是毒理学实验室中资讯学和数据解决方案的整合。敏感的测试结果安全地储存在质谱资料库中，凸显了资料完整性和保密性在该行业中的重要性。

该报告考察了北美毒理学实验室市场，并提供了市场概述，包括依药物类别、产品类型、样本、国家、公司以及进入市场的公司的竞争趋势划分的趋势。

目录

第一章执行摘要

第二章市场概况

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 经济概况
  • 杵分析

第三章 2018-2030年北美毒理学实验室市场展望

  • 北美毒理学实验室市场展望，依药物类别、价值（百万美元），2018-2030 年
  • 北美毒理学实验室市场展望，依产品类型和价值（百万美元），2018-2030 年
  • 北美毒理学实验室市场展望，依样本，价值（百万美元），2018-2030
  • 北美毒理学实验室市场展望，依国家/地区划分，价值（百万美元），2018-2030 年

第四章 竞争状况

  • 2022 年企业市占率分析
  • 主要公司的市场集中度
  • 比赛仪表板
  • 公司简介
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories, Inc.
    • NEOGEN Corporation
    • Redwood Toxicology Laboratory, Inc.
    • Vala Sciences, Inc.
    • Enzo Life Sciences, Inc.
    • Alere, Inc.
    • Agilent Technologies, Inc.
    • Immunalysis Corporation
    • Danaher Corporation
    • Principle Diagnostics Laboratory
    • Principle Laboratory
    • Principle Diagnostics Laboratory
    • Clinical Reference Laboratory, Inc.
    • Medical Toxicology Laboratory, LLC
    • NMS Labs
    • BATTS Laboratories
    • Total Toxicology
    • Life Brite Labs.
    • Product Safety Labs
    • Lexar Labs

第5章附录

简介目录

The North America toxicology laboratories market, unveiling promising forecasts and insightful trends driving the industry's evolution. With an impeccable Compound Annual Growth Rate (CAGR) of 10.4% projected during the forecast period, the market is expected to surge from US$255.2 million in 2023 to an estimated US$511.2 million by the end of 2030.

Rapid Screening Technologies: A Key Driver of Growth

The report highlights the increasing significance of rapid screening technologies as a primary trend propelling market expansion. With advancements in technologies such as Gas Chromatography-Mass Spectrometry (GC-MS), toxicology laboratories are witnessing a surge in demand for efficient screening methods, enhancing turnaround times and sensitivity.

Integration of Informatics and Data Solutions

Another pivotal trend identified in the report is the integration of informatics and data solutions within toxicology laboratories. Confidential test results are securely stored in mass spectral databases, emphasizing the importance of data integrity and confidentiality in the industry.

Key Segment Insights

  • Drug Class Dominance: Amphetamines emerge as the leading segment, capturing 17.9% of the market share and projected to grow at a robust CAGR of 11.0% during the forecast period.
  • Product Type Leadership: Reagent and kits claim the majority share of 61.6%, expected to grow at a steady CAGR of 9.7% over the forecast period.

Regulatory Frameworks Fueling Market Growth

The report underscores the role of robust regulatory frameworks in driving market growth across industries such as pharmaceuticals, cosmetics, food, and chemicals. Stricter regulations in the US and Canada mandate rigorous testing, creating a conducive environment for market expansion.

Challenges and Opportunities

While traditional toxicology laboratories face challenges from the introduction of point-of-care testing devices, increasing government spending on toxicity testing presents lucrative opportunities for market players. Collaborations between regulatory bodies and industry stakeholders further stimulate innovation and growth.

Competitive Analysis

Prominent organizations are spearheading the sector with innovative solutions and strategic alliances. Competitive intelligence and strategic decision-making remain crucial for companies navigating the dynamic landscape of the toxicology laboratories market.

Global North America Toxicology Laboratories Market:

  • Thermo Fisher Scientific, Inc.
  • Bio Rad Laboratories Inc.
  • Neogen Corporation
  • Danaher Corporation
  • Agilent
  • Redwood Toxicology Laboratory
  • Abbott (Alere, Inc.)

Global North America Toxicology Laboratories Market Is Segmented as Below:

Drug Class:

  • Alcohol
  • Amphetamines
  • Barbiturates
  • Benzodiazepines
  • Illicit Drugs
  • Opiates/Opioids
  • Tricyclic's Antidepressants
  • Z Drugs
  • Misc

Product Type:

  • Reagent Kits
    • ELISA
    • PCR
    • Enzyme Multiplied Immunoassay Technique (EMIT)
    • Radio Immuno-sorbent Assay (RIA)
  • Instruments
    • Immunochemistry Analyzers
    • PCR Machine
    • Gas Chromatography/Mass Spectrometry (GS/MS)
    • High Performance Liquid Chromatography (HPLC)

Sample:

  • Urine
  • Blood
  • Hair
  • Oral Fluid

End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Rehabilitation Centers

By Geographic Coverage:

  • North America
    • U.S.
    • Canada

Table of Contents

1. Executive Summary

  • 1.1. North America Toxicology Laboratories Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. Covid-19 Impact Analysis
    • 2.5.1. Overview
    • 2.5.2. Impact By Region
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. North America Toxicology Laboratories Market Outlook, 2018 - 2030

  • 3.1. North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. Alcohol
      • 3.1.1.2. Amphetamines
      • 3.1.1.3. Barbiturates
      • 3.1.1.4. Benzodiazepines
      • 3.1.1.5. Illicit Drugs
      • 3.1.1.6. Opiates/Opioids
      • 3.1.1.7. Tricyclic's Antidepressants
      • 3.1.1.8. Z Drugs
      • 3.1.1.9. Others
  • 3.2. North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Reagent Kits
        • 3.2.1.1.1. ELISA
        • 3.2.1.1.2. PCR
        • 3.2.1.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
        • 3.2.1.1.4. Radio Immuno-sorbent Assay (RIA)
      • 3.2.1.2. Instruments
        • 3.2.1.2.1. Immunochemistry Analyzers
        • 3.2.1.2.2. PCR Machine
        • 3.2.1.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
        • 3.2.1.2.4. High Performance Liquid Chromatography (HPLC)
  • 3.3. North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Urine
      • 3.3.1.2. Blood
      • 3.3.1.3. Hair
      • 3.3.1.4. Oral Fluid
    • 3.3.2. Market Attractiveness Analysis
  • 3.4. North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 3.4.1. Key Highlights
      • 3.4.1.1. U.S. Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
      • 3.4.1.2. U.S. Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
      • 3.4.1.3. U.S. Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
      • 3.4.1.4. Canada Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
      • 3.4.1.5. Canada Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
      • 3.4.1.6. Canada Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
    • 3.4.2. Market Attractiveness Analysis

4. Competitive Landscape

  • 4.1. Company Market Share Analysis, 2022
  • 4.2. Market Concentration by Top Players
  • 4.3. Competitive Dashboard
  • 4.4. Company Profiles
    • 4.4.1. Thermo Fisher Scientific
      • 4.4.1.1. Company Overview
      • 4.4.1.2. Product Portfolio
      • 4.4.1.3. Financial Overview
      • 4.4.1.4. Business Strategies and Development
    • 4.4.2. Bio-Rad Laboratories, Inc.
      • 4.4.2.1. Company Overview
      • 4.4.2.2. Product Portfolio
      • 4.4.2.3. Financial Overview
      • 4.4.2.4. Business Strategies and Development
    • 4.4.3. NEOGEN Corporation
      • 4.4.3.1. Company Overview
      • 4.4.3.2. Product Portfolio
      • 4.4.3.3. Financial Overview
      • 4.4.3.4. Business Strategies and Development
    • 4.4.4. Redwood Toxicology Laboratory, Inc.
      • 4.4.4.1. Company Overview
      • 4.4.4.2. Product Portfolio
      • 4.4.4.3. Financial Overview
      • 4.4.4.4. Business Strategies and Development
    • 4.4.5. Vala Sciences, Inc.
      • 4.4.5.1. Company Overview
      • 4.4.5.2. Product Portfolio
      • 4.4.5.3. Financial Overview
      • 4.4.5.4. Business Strategies and Development
    • 4.4.6. Enzo Life Sciences, Inc.
      • 4.4.6.1. Company Overview
      • 4.4.6.2. Product Portfolio
      • 4.4.6.3. Financial Overview
      • 4.4.6.4. Business Strategies and Development
    • 4.4.7. Alere, Inc.
      • 4.4.7.1. Company Overview
      • 4.4.7.2. Product Portfolio
      • 4.4.7.3. Financial Overview
      • 4.4.7.4. Business Strategies and Development
    • 4.4.8. Agilent Technologies, Inc.
      • 4.4.8.1. Company Overview
      • 4.4.8.2. Product Portfolio
      • 4.4.8.3. Financial Overview
      • 4.4.8.4. Business Strategies and Development
    • 4.4.9. Immunalysis Corporation
      • 4.4.9.1. Company Overview
      • 4.4.9.2. Product Portfolio
      • 4.4.9.3. Financial Overview
      • 4.4.9.4. Business Strategies and Development
    • 4.4.10. Danaher Corporation
      • 4.4.10.1. Company Overview
      • 4.4.10.2. Product Portfolio
      • 4.4.10.3. Financial Overview
      • 4.4.10.4. Business Strategies and Development
    • 4.4.11. Principle Diagnostics Laboratory
      • 4.4.11.1. Company Overview
      • 4.4.11.2. Product Portfolio
      • 4.4.11.3. Financial Overview
      • 4.4.11.4. Business Strategies and Development
    • 4.4.12. Principle Laboratory
      • 4.4.12.1. Company Overview
      • 4.4.12.2. Product Portfolio
      • 4.4.12.3. Financial Overview
      • 4.4.12.4. Business Strategies and Development
    • 4.4.13. Principle Diagnostics Laboratory
      • 4.4.13.1. Company Overview
      • 4.4.13.2. Product Portfolio
      • 4.4.13.3. Financial Overview
      • 4.4.13.4. Business Strategies and Development
    • 4.4.14. Clinical Reference Laboratory, Inc.
      • 4.4.14.1. Company Overview
      • 4.4.14.2. Product Portfolio
      • 4.4.14.3. Financial Overview
      • 4.4.14.4. Business Strategies and Development
    • 4.4.15. Medical Toxicology Laboratory, LLC
      • 4.4.15.1. Company Overview
      • 4.4.15.2. Product Portfolio
      • 4.4.15.3. Financial Overview
      • 4.4.15.4. Business Strategies and Development
    • 4.4.16. NMS Labs
      • 4.4.16.1. Company Overview
      • 4.4.16.2. Product Portfolio
      • 4.4.16.3. Financial Overview
      • 4.4.16.4. Business Strategies and Development
    • 4.4.17. BATTS Laboratories
      • 4.4.17.1. Company Overview
      • 4.4.17.2. Product Portfolio
      • 4.4.17.3. Financial Overview
      • 4.4.17.4. Business Strategies and Development
    • 4.4.18. Total Toxicology
      • 4.4.18.1. Company Overview
      • 4.4.18.2. Product Portfolio
      • 4.4.18.3. Financial Overview
      • 4.4.18.4. Business Strategies and Development
    • 4.4.19. Life Brite Labs.
      • 4.4.19.1. Company Overview
      • 4.4.19.2. Product Portfolio
      • 4.4.19.3. Financial Overview
      • 4.4.19.4. Business Strategies and Development
    • 4.4.20. Product Safety Labs
      • 4.4.20.1. Company Overview
      • 4.4.20.2. Product Portfolio
      • 4.4.20.3. Financial Overview
      • 4.4.20.4. Business Strategies and Development
    • 4.4.21. Lexar Labs
      • 4.4.21.1. Company Overview
      • 4.4.21.2. Product Portfolio
      • 4.4.21.3. Financial Overview
      • 4.4.21.4. Business Strategies and Development

5. Appendix

  • 5.1. Research Methodology
  • 5.2. Report Assumptions
  • 5.3. Acronyms and Abbreviations